News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Curis, Inc. (CRIS) Announces Publication of Erivedge(TM) Data in The New England Journal of Medicine



6/7/2012 9:24:10 AM

LEXINGTON, Mass., June 7, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that two publications describing clinical data generated with Erivedge™ (vismodegib, GDC-0449) capsule were published in the current edition of The New England Journal of Medicine (NEJM).

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES